Jason C. Jones - 06 Jan 2026 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Chief Operating Officer
Signature
/s/ Jerome Wong
Issuer symbol
EKSO
Transactions as of
06 Jan 2026
Net transactions value
-$12,210
Form type
4
Filing time
07 Jan 2026, 16:45:57 UTC
Previous filing
10 Dec 2025
Next filing
20 Mar 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Jason C. Jones filed Form 4 for EKSO BIONICS HOLDINGS, INC. (EKSO) on 07 Jan 2026."

Quick Takeaways

  • This page summarizes Jason C. Jones's Form 4 filing for EKSO BIONICS HOLDINGS, INC. (EKSO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 07 Jan 2026, 16:45.

What Changed

  • Previous filing in this sequence was filed on 10 Dec 2025.
  • Current net transaction value: -$12,210.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jones Jason C Chief Operating Officer 101 GLACIER POINT, SUITE A, SAN RAFAEL /s/ Jerome Wong 07 Jan 2026 0001775619

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Sale $12,210 -1,320 -4.9% $9.25 25,621 06 Jan 2026 Direct F1, F2, F3
holding EKSO Common Stock 3,141 06 Jan 2026 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person on January 6, 2026 to cover tax withholding obligations incurred upon the vesting and settlement of restricted stock awards originally reported by the Reporting Person in a Form 4 filed with the Commission on June 15, 2023.
F2 These shares were sold in a single transaction at a price of $9.25 per share.
F3 On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Sponsored